The Future of R&D in Pharmaceutical Industry in 2025
EMBA09 team:
Murat Akguc
Ruth Donners
Peter Friedl
Susan Liu
Eva Stjernschantz
Work under construction.
Scenarios
Driving forces
Edited existing ones
• Increasing potential to grow based on new available technology
• Struggling old world economy
• Increasing Empowerment of Consumers in Healthcare System
• Continuously growing demand for new medical applications
• The increasing gap between developed, emerging and poor economies
• The increasing globalization of markets
• Power of the United Nations
• Legal Restrictions for Biotech increasing in certain countries, decreasing in others
two more will be added
Added new ones
• IP rights
• Logistics/Distribution
• Illnesses of global importance/Pandemics
• Research budget in pharmaceutical industry
• Effect of development of health care system in emerging market countries to existing pharmaceutical industry
• Unification of regulatory approval
• Competitiveness through innovation in biotechnology
• New business models for pharmaceutical industry
two more will be added